Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 28, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Market Capitalization	69	76	-	-
Enterprise Value	67	76	-	-
Last Close Price	1.15	1.50	-	-
PS Ratio	442.89	1164.95	-	-
PB Ratio	176.19	42.13	-	-
P/TBV Ratio	176.19	42.13	-	-
EV/Sales Ratio	-	1158.58	-	-
Net Debt / Equity Ratio	-1.32	-0.62	-1.40	-1.00
Asset Turnover	-	0.05	-	-
Quick Ratio	1.23	2.94	3.47	-
Current Ratio	1.87	5.41	3.47	-
Return on Equity (ROE)	-	-799.79%	-233.40%	-
Return on Assets (ROA)	-	-144.12%	-105.54%	-
Return on Capital Employed (ROCE)	-1947.20%	-170.10%	-123.50%	-1.30%
Earnings Yield	-21.78%	-11.17%	-	-
Buyback Yield / Dilution	-9693.55%	-905.82%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.